(Bold for FDA approved)
How Navane works• Blocks dopamine 2 receptors, reducing positive symptoms of psychosis
• Psychotic symptoms can improve within 1 week, but it may take several weeks for full effect on behavior
Notable Side Effects• Neuroleptic-induced deficit syndrome
• Akathisia
• Drug-induced parkinsonism
• Tardive dyskinesia
• Risk of potentially irreversible involuntary dyskinetic movements may increase with cumulative dose and treatment duration
• Galactorrhea, amenorrhea
• Sedation
• Dry mouth, constipation, vision disturbance, urinary retention
• Hypotension, tachycardia
• Rare fine lenticular pigmentation
Life Threatening Side Effects• Rare neuroleptic malignant syndrome may cause hyperpyrexia, muscle rigidity, delirium, and autonomic instability with elevated creatine phosphokinase, myoglobinuria (rhabdomyolysis), and acute renal failure
• Rare seizures
• Rare blood dyscrasias
• Rare hepatic toxicity
• As a class, antipsychotics are associated with an increased risk of death and cerebrovascular events in elderly patients with dementia; not approved for treatment of dementia-related psychosis

unusual

not usual
• Wait
• Wait
• Wait
• For drug-induced parkinsonism, add an anticholinergic agent
• Beta blockers, benzodiazepines, or serotonin 2A antagonists (e.g., mirtazapine, cyproheptadine) may reduce akathisia
• For sedation, take at night
• Reduce the dose
• Switch to an atypical antipsychotic
• Weight loss, exercise programs, and medical management for high BMIs, diabetes, dyslipidemia
• Metformin may help prevent or reverse antipsychotic-induced weight gain
• 15–30 mg/day
Dosage Forms• Capsule 2 mg, 5 mg, 10 mg
• Should periodically reevaluate long-term usefulness in individual patients, but treatment may need to continue for many years
• No
Renal Impairment• Use with caution
Hepatic Impairment• Use with caution
Cardiac Impairment• Thiothixene may cause or aggravate ECG changes
• Use in patients with cardiac impairment has not been studied, so use with caution because of risk of orthostatic hypotension
• Use with caution if patient is taking concomitant antihypertensive or alpha 1 antagonist
Elderly• Some patients may tolerate lower doses better
• Although conventional antipsychotics are commonly used for behavioral disturbances in dementia, no agent has been approved for treatment of elderly patients with behavioral symptoms of dementia such as agitation
• Elderly patients with dementia-related psychosis treated with antipsychotics are at an increased risk of death compared to placebo, and also have an increased risk of cerebrovascular events
Children and Adolescents• Safety and efficacy have not been established in children under age 12
• Generally consider second-line after atypical antipsychotics
Pregnancy• Controlled studies have not been conducted in pregnant women
• There is a risk of abnormal muscle movements and withdrawal symptoms in newborns whose mothers took an antipsychotic during the third trimester; symptoms may include agitation, abnormally increased or decreased muscle tone, tremor, sleepiness, severe difficulty breathing, and difficulty feeding
• Reports of drug-induced parkinsonism, jaundice, hyperreflexia, hyporeflexia in infants whose mothers took a phenothiazine during pregnancy
• Psychotic symptoms may worsen during pregnancy and some form of treatment may be necessary
• Atypical antipsychotics may be preferable to conventional antipsychotics or anticonvulsant mood stabilizers if treatment is required during pregnancy
• Thiothixene should generally not be used during the first trimester
• Thiothixene should be used during pregnancy only if clearly needed
Breast Feeding• Unknown if thiothixene is secreted in human breast milk, but all psychotropics are assumed to be secreted in breast milk
• Recommended either to discontinue drug or bottle feed
Based on data Published online by Cambridge University Press
Compiled by Dr. Jash Ajmera